Valuation: BOIRON

Market Cap 465M 531M 432M 397M 748M 51.26B 759M 5.15B 2.01B 25.08B 1.99B 1.95B 86.59B P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 417M 476M 388M 356M 671M 45.99B 681M 4.62B 1.81B 22.5B 1.79B 1.75B 77.68B EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 week-2.55%
Current month-3.25%
1 month-3.25%
3 months+3.08%
6 months-11.84%
Current year-11.55%
1 week 26.4
Extreme 26.4
27.2
1 month 26.4
Extreme 26.4
28.2
Current year 24.35
Extreme 24.35
30.95
1 year 20.85
Extreme 20.85
32.25
3 years 20.85
Extreme 20.85
56.5
5 years 20.85
Extreme 20.85
56.5
10 years 20.85
Extreme 20.85
92.91
Manager TitleAgeSince
Chief Executive Officer 57 2024-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Chairman 65 2011-06-30
Director/Board Member 54 2010-03-09
Director/Board Member 51 2013-05-22
Date Insider Type Main position Quantity % Market Cap.
10/29/23 Sell 858,660 4.8939%
10/29/23 Sell

Director

198,664 1.1323%
10/29/23 Sell

Chairman

4,748 0.0271%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-2.55%+22.10%-46.61% 531M
+1.07%+3.40%-7.87%-3.25% 13.49B
+0.35%+5.01%-27.66%-49.96% 5.25B
+0.76%+4.83%+3.71%-0.69% 4.81B
-0.06%+0.52%+12.98%-28.76% 4.26B
-1.10%-4.32%+5.43%-7.35% 3.78B
+1.03%+8.79%-1.08%-0.11% 3.7B
+0.25%+9.66%-1.36%+13.23% 3.52B
+1.27%+0.76%-10.51%-20.44% 2.46B
+0.04%-1.23%-3.20%+48.28% 1.86B
Average +0.36%-0.94%-0.75%-9.57% 4.37B
Weighted average by Cap. +0.54%-0.76%-4.27%-9.12%

Financials

2024 2025
Net sales 488M 556M 453M 416M 784M 53.72B 796M 5.39B 2.11B 26.28B 2.09B 2.04B 90.73B 501M 572M 466M 428M 805M 55.21B 818M 5.54B 2.17B 27.01B 2.15B 2.1B 93.25B
Net income 11.34M 12.93M 10.53M 9.67M 18.22M 1.25B 18.5M 125M 49.02M 611M 48.54M 47.48M 2.11B 32.64M 37.25M 30.33M 27.85M 52.46M 3.6B 53.28M 361M 141M 1.76B 140M 137M 6.07B
Net Debt -49.74M -56.75M -46.21M -42.44M -79.93M -5.48B -81.18M -550M -215M -2.68B -213M -208M -9.26B -47.86M -54.6M -44.46M -40.83M -76.9M -5.27B -78.11M -529M -207M -2.58B -205M -200M -8.91B
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
2,499
Date Price Change Volume
26-07-22 €26.80 0.00% 499
26-07-21 €26.80 -0.74% 1,587
26-07-20 €27.00 +0.75% 2,755
26-07-17 €26.80 -0.74% 6,024
26-07-16 €27.00 -1.82% 2,657

Annual profits - Rate of surprise